-
1
-
-
0029952658
-
-
with the EuroQol Group EuroQol: the current state of play
-
Brooks R, with the EuroQol Group EuroQol: the current state of play. Health Pol 1996; 37: 53-72.
-
(1996)
Health Pol.
, vol.37
, pp. 53-72
-
-
Brooks, R.1
-
2
-
-
0032492429
-
Variations in population health status: Results from a United Kingdom national questionnaire survey
-
Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J 1998; 316: 736-741.
-
(1998)
Br. Med. J.
, vol.316
, pp. 736-741
-
-
Kind, P.1
Dolan, P.2
Gudex, C.3
Williams, A.4
-
3
-
-
0031279593
-
Modelling valuations for EuroQol health states
-
Dolan P. Modelling valuations for EuroQol health states. Med Care 1997; 35: 1095-1108.
-
(1997)
Med. Care
, vol.35
, pp. 1095-1108
-
-
Dolan, P.1
-
4
-
-
0034955556
-
Recognizing diversity in public preferences: The use of preference sub-groups in cost-effectiveness analysis
-
Sculpher M, Gafni A. Recognizing diversity in public preferences: the use of preference sub-groups in cost-effectiveness analysis. Health Econ 2001; 10: 317-324.
-
(2001)
Health Econ.
, vol.10
, pp. 317-324
-
-
Sculpher, M.1
Gafni, A.2
-
5
-
-
0030102792
-
The Time Trade-Off Method: Results from a General Population Study
-
Dolan P, Gudex C, Kind P, Williams A. The Time Trade-Off Method: Results from a General Population Study. Health Econ 1996; 5(2): 141-154.
-
(1996)
Health Econ.
, vol.5
, Issue.2
, pp. 141-154
-
-
Dolan, P.1
Gudex, C.2
Kind, P.3
Williams, A.4
-
6
-
-
0036169017
-
The estimation of a preference based measure of health from the SF-36
-
Brazier J, Roberts J, Deverill M. The estimation of a preference based measure of health from the SF-36. J Health Econ 2002; 21: 271-292.
-
(2002)
J. Health Econ.
, vol.21
, pp. 271-292
-
-
Brazier, J.1
Roberts, J.2
Deverill, M.3
-
7
-
-
4344592532
-
NICE Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis
-
NICE Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. Technol Appr Guid 2002; No. 36.
-
(2002)
Technol. Appr. Guid.
, vol.36
-
-
-
8
-
-
4344646153
-
The clinical effectiveness and cost effectiveness of new drug treatments for rheumatoid arthritis: Etanercept and infliximab
-
Jobanputra P, Barton P, Bryan S, Fry-Smith A, Burls A. The clinical effectiveness and cost effectiveness of new drug treatments for rheumatoid arthritis: etanercept and infliximab. NHS HTA 2001: 6(21).
-
(2001)
NHS HTA
, vol.6
, Issue.21
-
-
Jobanputra, P.1
Barton, P.2
Bryan, S.3
Fry-Smith, A.4
Burls, A.5
-
9
-
-
0035103270
-
Short-term effects of severe hypoglycaemia in children and adolescents with Type 1 diabetes. A cost of illness study
-
Nordfeldt S, Jonsson D. Short-term effects of severe hypoglycaemia in children and adolescents with Type 1 diabetes. A cost of illness study. Acta Paediatr 2001: 90(2): 137-142.
-
(2001)
Acta Paediatr.
, vol.90
, Issue.2
, pp. 137-142
-
-
Nordfeldt, S.1
Jonsson, D.2
|